Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,457 | 80,981 | 75,760 | 86,168 | 101,494 |
| Marketable Securities | 88,334 | 101,623 | 124,018 | 148,151 | 162,995 |
| Receivables | 274 | 7,191 | 431 | 406 | 5,930 |
| Other current assets | 3,248 | 3,863 | 4,571 | 5,902 | 4,303 |
| TOTAL | $170,313 | $193,658 | $204,780 | $240,627 | $274,722 |
| Non-Current Assets | |||||
| PPE Net | 88,882 | 91,378 | 93,868 | 96,693 | 97,363 |
| Other Non-Current Assets | 104,520 | 104,641 | 105,483 | 105,223 | 105,318 |
| TOTAL | $193,402 | $196,019 | $199,351 | $201,916 | $202,681 |
| Total Assets | $363,715 | $389,677 | $404,131 | $442,543 | $477,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,877 | 4,489 | 4,863 | 5,246 | 5,547 |
| Accounts payable and accrued liabilities | 13,910 | 3,213 | 15,428 | 17,233 | 16,791 |
| Accrued Expenses | N/A | 12,414 | N/A | N/A | N/A |
| TOTAL | $17,823 | $20,116 | $21,267 | $23,932 | $32,757 |
| Non-Current Liabilities | |||||
| Long Term Debt | 48,526 | 49,152 | 50,129 | 51,205 | 52,403 |
| Deferred Revenues | 36 | N/A | 976 | 1,453 | 10,419 |
| Other Non-Current Liabilities | 5,663 | 5,693 | 6,259 | 5,634 | 8,413 |
| TOTAL | $54,189 | $54,845 | $56,388 | $56,839 | $60,816 |
| Total Liabilities | $72,012 | $74,961 | $77,655 | $80,771 | $93,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,988 | 37,906 | 37,884 | 37,867 | 37,722 |
| Common Shares | 38 | 38 | 38 | 38 | 38 |
| Retained earnings | -433,071 | -407,351 | -392,639 | -353,496 | -326,047 |
| Other shareholders' equity | 324 | 99 | -328 | -1,310 | -1,184 |
| TOTAL | $291,703 | $314,716 | $326,476 | $361,772 | $383,830 |
| Total Liabilities And Equity | $363,715 | $389,677 | $404,131 | $442,543 | $477,403 |